SCARPELLI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 240
EU - Europa 223
AS - Asia 80
Continente sconosciuto - Info sul continente non disponibili 1
Totale 544
Nazione #
US - Stati Uniti d'America 240
IE - Irlanda 68
UA - Ucraina 60
IT - Italia 34
HK - Hong Kong 26
VN - Vietnam 20
SG - Singapore 16
DE - Germania 15
FI - Finlandia 14
FR - Francia 11
KR - Corea 9
RU - Federazione Russa 9
CN - Cina 8
CZ - Repubblica Ceca 3
CH - Svizzera 2
RO - Romania 2
SE - Svezia 2
AT - Austria 1
EU - Europa 1
GB - Regno Unito 1
NL - Olanda 1
TR - Turchia 1
Totale 544
Città #
Chandler 69
Dublin 68
Jacksonville 36
San Mateo 27
Hong Kong 26
Dong Ket 20
Singapore 13
Medford 12
Princeton 12
Perugia 11
Seoul 9
Andover 6
Beijing 5
Wilmington 5
Altamura 4
Ann Arbor 4
Foligno 4
Lawrence 4
Norwalk 4
Brno 3
Boardman 2
Helsinki 2
Avellino 1
Den Haag 1
Falkenstein 1
Florence 1
Izmir 1
Lausanne 1
Reghin 1
Rome 1
San Severo 1
Timisoara 1
Totale 356
Nome #
Well differentiated thoracic neuroendocrine tumors: clinical management and therapy 63
Analoghi della somatostatina nei tumori neuroendocrini gastro-entero-pancreatici e toracici 61
18F-deoxy-D-glucose positron emission tomography (FDG_PET) increases the detection rate of recurrent or residual medullary thyroid cancer 54
Evaluation of accuracy of circulating CgA and NSE in the pre- and post-operative phase in bronchial carcinoids 53
Shortened interval of octreotide LAR administration is effective in patients with well differentiated neuroendocrine carcinomas in progression on standard doses. 50
Surgical treatment of well differentiated neuroendocrine tumours of the lung 49
Comorbilità di ansia e depressione nei pazienti con tumori carcinoidi - Comorbility between anxiety and depression in patients with carcinoid tumors - 45
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses. 44
The biological characterization of neuroendocrine tumors: the role of neuroendocrine markers. 40
macro-prolactinomas:which the therapeutic space of dopamine-agonists? 39
LA TERAPIA DEI PROLATTINOMI IN TEMPO DI SPENDING REVIEW. BROMOCRIPTINA vs CABERGOLINA: ANALISI COSTO-EFFICACIA 36
CD 44 expression as a major prognostic factor in lung neuroendocrine tumors 33
Totale 567
Categoria #
all - tutte 2.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202054 3 0 9 0 9 3 10 0 11 4 2 3
2020/2021100 0 9 1 9 33 0 9 1 9 0 9 20
2021/202274 0 15 1 0 0 0 0 32 1 1 12 12
2022/2023198 12 20 7 9 21 15 0 16 82 0 10 6
2023/202465 6 3 5 2 1 1 16 0 10 0 8 13
2024/202511 11 0 0 0 0 0 0 0 0 0 0 0
Totale 567